59results about How to "Treat high blood pressure" patented technology

The invention provides methods for (a) prolonging time to hospitalization for heart failure; (b) prolonging time to first hospitalization for heart failure; (c) reducing the total number of days a patient with heart failure spends in the hospital for heart failure for a single hospital stay (i.e., reducing the duration of a single hospital stay for a patient with heart failure); (d) reducing the total number of days a patient spends in the hospital for heart failure for multiple hospital stays (i.e., two or more hospital stays); (e) reducing the number of hospital admissions for heart failure; (f) reducing mortality and reducing hospitalizations for heart failure (e.g., the total number of days in the hospital and / or the number of hospital visits); (g) increasing the left ventricular ejection fraction in a heart failure patient; (h) treating a sexual dysfunction (e.g., erectile dysfunction and female sexual dysfunction) (j) treating a headache in a heart failure patient by administering a non-steroidal antiinflammatory compound (i.e., NSAIDs); (k) treating a heart failure patient who has a history of hypertension (but who is not currently diagnosed with hypertension); (l) improving the quality of life in a heart failure patient based on the Minnesota Living with heart failure questionnaire; (m) decreasing the levels of B-type natriuretic peptide; (n) treating hypertension in a heart failure patient; (o) lowering blood pressure in a heart failure patient; (p) treating labile hypertension; (q) treating idiopathic hypertension; (r) increasing patient compliance with medication dosing in a heart failure patient; (s) treating hypertension in a patient with a dilated heart; (t) treating ischemic disease and / or coronary artery disease; and (u) reducing cardiomegaly in a patient in need thereof comprising administering to the patient a therapeutically effective amount of (i) a hydralazine compound or pharmaceutically acceptable salt thereof, (ii) isosorbide dinitrate and / or isosorbide mononitrate, and (iii) optionally at least one compound selected from the group consisting of angiotensin converting enzyme inhibitors, β-adrenergic antagonists, angiotensin II antagonists, aldosterone antagonists, cardiac glucosides (digitalis), and diuretic compounds.

The invention relates to a mango banana fruit wine and a production method thereof. The production method comprises the steps of peeling and denucleating fresh mangos, beating the fruit pulp of the mangos into pulp by using a beating machine, and placing the pulp into a fermentation tank; peeling bananas, beating the bananas into pulp by using a pulverizing machine, and placing the pulp into the fermentation tank; pouring crystal sugar which is ground into powder into the fermentation tank according to a ratio, performing pasteurization at 70 DEG C, adding activated yeast and performing anaerobic fermentation, wherein the fermentation tank is a wood barrel, a colored glass jar or a ceramic tank, the temperature is 20-30 DEG C and the time is controlled to be 8 to 20 days, so that fermentation can be performed completely; detecting, filtering and filling to obtain a product, wherein the alcoholic strength is 10-12 degrees. The fruit wine provided by the invention is a healthy drink with the effects of preventing and treating cardiovascular diseases, clearing the intestines and stomach, treating constipation, clearing heat, moistening the lung, resisting polydipsia, replenishing essence, relieving alcoholism and the like.

The present invention relates to a duck feed capable of making duck egg have the functions of softening blood vessel and reducing blood pressure. The duck feed composition includes (by wt%) 63-64% of corn, 19-20% of soybean cake, 6.5-7.5% of animal bone powder, 0.8-1.2% of oil, 7.5-8.5% of stone powder, 0.5-0.7% of calcium hydrogen phosphate, 0.12-0.18% of edible salt, 0.08-0.12% of methionine and 0.13-0.17% of vitamins and microelements. Besides, 5-10g of detoxicated ginkgo leaf, 10-20g of crataegus fruit, 6-15g of crataegus leaf, 5-10g of clerodendron leaf, 5-10g of aristolochia root, 3-8g of prunella spike and 10-20g of persimmon leaf are added into the above-mentioned main raw material.

The invention discloses a dendrobe oral solution for fast postpartum recovery. The dendrobe oral solution comprises the following components in parts by weight: 75-88 parts of dendrobium officinale, 5-8 parts of herba leonuri, 3-5 parts of American ginseng, 3-5 parts of angelica sinensis, 2-3 parts of astragalus membranaceus, 2-4 parts of folium artemisiae argyi, 2-3 parts of honeysuckle vines, 4-6 parts of spina date seed, 1-2 parts of raspberry, 3-5 parts of fruit of Chinese wolfberry, 3-5 parts of peanut coat, 2-3 parts of lily, 4-5 parts of walnut, 3-4 parts of longan, 8-10 parts of brown sugar, 2-4 parts of cooked sesame powder, 3-5 parts of honey, 2-3 parts of hawthorn, 4-5 parts of apple, 3-5 parts of banana, 4-6 parts of Chinese yam, 8-12 parts of nutrient solution, and 3,000-3200 parts of water. According to the dendrobe oral solution, beneficial elements of natural resources are supplemented to a body by utilizing reasonable proportions of traditional Chinese medicinal materials and recuperating by food in view of the phenomena, such as poor health and nutrient loss after childbirth, and the fast postpartum recovery effect is achieved.

The present invention discloses a peach bamboo tea using fruit tree plant as main raw material. Its composition comprises dried peach fruit, dried peach leaf, dried peach flower, dried tree root, bamboo leaf and green tea. Said invention can be used for directly curing diabetes (insulin dependence and chronic complicating disease), at the same time can be used for curing the diseases of hypertension, amenorrhea, constipation, senile dementia and cerebral thrombosis, etc. and can be used for regulating immunity of human body and activating immune interferon of human body self-body complement system to attain the goal of implementing synchronous health-care and therapy.

The invention discloses a brewing method of miracle fruit fermented wine, which comprises the steps of raw material selection, cleaning, juicing and enzymolysis, fermenting, clarifying filtration, ageing, sterile filling and the like. The brewing method is simple, the equipment investment cost is low, and the comprehensive utilization rate of the miracle fruit is increased greatly; the miracle fruit fermented wine brewed by the brewing method not only keeps the sweet characteristic of the miracle fruit and has the sweet and mellow flavor of the fruit wine at the same time, is free from chemical additives such as preservatives and pigment artificially, is green and healthy, remains the original nutritional ingredients of the miracle fruit completely, is nutritious and healthy fruit wine, and has a certain effect on the treatment of high blood pressure, hyperlipidemia and arteriosclerosis.

The invention belongs to the technical field of health flower tea, and particularly relates to skin nourishing tea containing trollflowers and roses and a preparation method thereof. The skin nourishing tea is prepared from the following components in parts by mass: 30-50 parts of black tea, 10-15 parts of licorice roots, 8-10 parts of pericarpium citri reticulatae, 3-5 parts of rhizoma atractylodis macrocephalae, 10-20 parts of dried trollflowers, 5-10 parts of rock candy, 5-10 parts of dried roses, 3-5 parts of astragalus membranaceus and 5-8 parts of codonopsis pilosula. The skin nourishingtea is simple in preparation method, can be easily implemented, is a multifunctional tea, has a preservation period of 15-16 months, has the effects of tranquilizing, calming and nourishing skin, andcan be used for accelerating elimination of toxin from a human body since licorice roots, pericarpium citri reticulatae, rhizoma atractylodis macrocephalae and other ingredients are added.

The invention discloses a cardiovascular protection medicinal composition, which comprises 5 to 200 mole parts of an angiotensin-converting enzyme inhibitor and 100,000 to 600,000 mass parts of an antioxidant. The invention also discloses the use of the medicinal composition and a blood substitute. The cardiovascular protection medicinal composition can be used for effectively protecting the cardiovascular system and lowering the cardiovascular side effects of a hemoglobin-based oxygen carrier. The blood substitute has no cardiovascular side effects, and has a broad clinical application prospect, and the shortcomings of a conventional hemoglobin blood substitute are overcome.

The invention discloses a pressure-stabilizing and lipid-decreasing coarse grain electuary and a preparation method thereof. The pressure-stabilizing and lipid-decreasing coarse grain electuary comprises the following raw materials in parts by weight: 37-39 parts of soybeans, 22-24 parts of corns, 6-8 parts of bran, 8-10 parts of black sesame, 5-7 parts of radix angelicae, 7-9 parts of semen coicis, 4-6 parts of green tea, 2-4 parts of lotus leaves, 11-13 parts of yellow wine, 5-7 parts of almond kernels, 6-8 parts of hazelnut kernels, 4-8 parts of glutinous rice flour, 1-3 parts of sweet-scented osmanthus, 2-4 parts of fresh ginger, 9-11 parts of oat and 8-10 parts of powdered sugar. The pressure-stabilizing and lipid-decreasing coarse grain electuary has rich nutrients and is capable of decreasing blood lipid and blood sugar.